Abstract
Tg Treg, the ratio of Foxp3 + to CD3 + cells was increased both in the colon and in mesenteric lymph nodes, and Teff cell proliferation as determined by staining with Ki67 was reduced. Teff cells from fgl2
Tg mice did not produce colitis.
INTRODUCTION
Inflammatory bowel disease (IBD) consists of a group of chronic relapsing inflammatory diseases of the gastrointestinal tract including Crohn's disease (CD) and ulcerative colitis [1] . The onset of colitis is dependent on dysregulated innate and adaptive immune responses to bacterial flora [1] [2] [3] [4] [5] . A well-characterized model of IBD caused by infusion of CD4
high effector T cells (Teff) into immunodeficient Rag1 -/-mice has been used to study the pathogenesis of IBD [2, 4, 5] .
Infusion of Teff cells into Rag1
-/-mice leads to the development of colitis [5] . Infusion of CD4 + CD25 + CD45RB low regulatory T cells (Treg) has been reported to be protective against the development of T-cell induced colitis [6, 7] . It is now known that Treg are a subset of CD4 + T cells that are characterized by the expression of the transcription factor Foxp3 [8] . Foxp3 + Treg are important in regulating host immune responses to pathogens and maintaining tolerance [9] . Foxp3 + Treg are comprised of functionally diverse subsets with distinct phenotypes and functions [10] . These cells are known to express a number of important suppressor molecules including IL-10, programmed cell death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) [11] . Recently, fibrinogenlike protein 2 (FGL2) has been identified to be an important effector molecule of Treg [10, 12] . FGL2 is a member of the fibrinogen-like family of proteins, which was first isolated from a cytotoxic T cell library [13] . When expressed by macrophages and endothelial cells, FGL2 has prothrombinase activity, which contributes to the pathogenesis of experimental and human viral hepatitis [14] [15] [16] . When expressed by T cells, FGL2 has immunoregulatory activity [12, 17] . The C-terminal of FGL2 contains a FRED domain, which accounts for the immunomodulatory activity and is important in regulating dendritic cell (DC) maturation, T cell proliferation and B cell apoptosis [12, 17] . We and others have reported that Treg that express high levels of FGL2 lead to tolerance of fully mismatched heart allografts [18] [19] [20] . Studies showed that tolerant grafts contained large numbers of Treg that co-expressed Foxp3 and FGL2, whereas rejecting grafts contained Foxp3 + Treg that were FGL2 negative. Depletion of Treg by antibody to CD25 or by a non-depleting antibody to FGL2 led to loss of tolerance and severe allograft rejection [18, 19] . We previously reported that mice lacking FGL2 (fgl2 -/-) have a reduction in Treg immunosuppressive activity and develop autoimmune glomerulonephritis [12] . In those studies we showed that T cells from fgl2 [12] . To further determine the role of FGL2 in immune function, we generated ubiquitous FGL2 over-expressing mice (fgl2 Tg ) [20] . Here we used these mice to determine the importance of FGL2 to the pathogenesis of IBD. We examined both the ability of fgl2
Tg T effector cells to induce colitis and the ability of fgl2 Tg Treg to prevent colitis. We hypothesized that the over-expression of FGL2 in Treg would lead to protection against T cellinduced colitis. 
MATERIALS AND METHODS

Animals
Generation of FGL2 Transgenic Mice (fgl2
Tg )
The generation of fgl2 Tg mice has been previously reported [20] . Briefly, a prothrombinase inactive fgl2 gene was inserted into the iZ/EG targeting vector, which was electroporated into R1 ES cells [21] . Chimeric mice were generated using the tetraploid embryo aggregation technique [21] . Following germline transmission, fgl2 LoxP mice were crossed with fgl2 -/-mice using the Jackson Laboratory speed congenic service followed by two crosses with EIIa-cre; fgl2 -/-mice to generate fgl2 Tg mice that co-overexpress FGL2 and EGFP ubiquitously. Fgl2
Tg mice used for these studies were further backcrossed to fgl2 -/-mice on the C57BL/6 background to generate fully congenic mice (N10).
Quantification of FGL2 expression
FGL2 concentrations in mouse plasma and culture supernatants were determined by a commercially available ELISA (BioLegend, United States).
Flow cytometry
Cells were stained using a standard method described by the manufacturer (eBioscience, United States). In brief, a single cell suspension was incubated with Fc Block (eBioscience) on ice for 20 min. Cells were stained with CD4-PC7, CD4-PE-Cy7, Foxp3-PE, CD45RB-APC (eBioscience) and CD25-PE (Miltenyi Biotec, United States) in the dark for 30 min at 4 ℃. Viability staining was performed using eFluor450 (eBioscience). For intracellular staining, cells previously stained for membrane proteins were fixed and permeabilized using a Fix/Perm kit (eBioscience). Cells were visualized using the BD LSRII analyzer (BD Biosciences, United States) and data were analyzed using FlowJo software, version 9.6 (Tree Star, United States).
One way-mixed lymphocyte reaction
Single cell suspensions of BALB/c SMNC were generated using standard methods. BALB/c SMNC were irradiated with 2000cGy using a γ-irradiator. 
Treg suppression assay
The Treg suppression assay was adapted from Shalev et al [12] . H-thymidine was added to culture supernatants and incubated for 18 h. Percent suppression was calculated as previously described [20] .
T cell-induced model of colitis
The T cell-dependent model of colitis was adapted from Ostanin et al [5] . Briefly, single cell suspensions of SMNC were enriched for CD4 + T cells using the 
Histology
Tissues were harvested and fixed in 10% buffered formalin solution. Following paraffin-embedding, tissues were sectioned at 4 µm. The hematoxylin and eosin (H&E) stains were employed using standard methods. Staining for CD3 + T cells and Foxp3 + Treg was performed with anti-mouse CD3 (17A2; eBioscience) and anti-mouse Foxp3 (FJK-16S; eBioscience) antibodies. T cell proliferation was assessed by staining formalin fixed tissues with a rat anti-mouse Ki67 (TEC-3; DAKO, Denmark) followed by anti-rat Ig (Vector Laboratories, Canada). Pathological scoring was performed by a blinded pathologist using the scoring system adapted from Aranda et al [3] . A maximum score values ≤ 0.05 were considered statistically significant.
RESULTS
Alterations in T cell proliferation and Treg suppressive activity in fgl2 Tg mice
We previously reported on the generation of fgl2 Tg mice that were backcrossed on a C57BL/6 background (N4) [20] . Here, we performed additional backcrosses to generate fully congenic fgl2 Tg mice (N10). Congenic fgl2 Tg mice maintained high expression of FGL2 with plasma levels of FGL2 that were approximately 9-fold higher than fgl2 +/+ mice (672.40 ± 117.6 ng/mL vs 75.43 ± 6.24 ng/mL, respectively) ( Figure 1A ). To examine the effect of over-expression of FGL2 on T cell proliferation, CD4 + T cells were isolated from Figure 1B ) [17] . Previously, we showed that fgl2 -/-Treg have decreased immunosuppressive activity and that Treg suppressive activity could be inhibited with anti-FGL2 antibody [12] . Additionally, we showed that fgl2 Tg Treg expressed significantly higher levels of FGL2 [20] . Here we found that there were no changes in the frequency of Foxp3 + of 12 points was awarded based on the inflammatory infiltrate in the lamina propria (0-3), the degree of mucin depletion in the large intestine (0-3), the degree of intra-epithelial lymphocytes in the crypts (0-3) and the % of surface area affected (0-3).
Morphometry
CD3 and Foxp3 stained slides were scanned using the Aperio ScanScrope Slide Scanner (Aperio Technologies, United States). Positively stained cells were counted with an algorithm developed with Spectrum software (Aperio Technologies).
Animal Care and Use Statement
All mice were housed in specific pathogen free conditions and fed a standard laboratory diet. Animals were treated in accordance with guidelines set by the Canadian Council for Animal Care and all appropriate measures were taken to minimize pain and discomfort. The animals were acclimatized to laboratory conditions (22 ℃, 12 h/12 h light/dark, 50% humidity, ad libitum access for food and water) for two weeks prior to experimentation. All animals were euthanized by barbiturate overdose for tissue collection.
Statistical analysis
Statistical significance was determined using Students t-test or a one-way or two-way ANOVA as indicated using PRISM v5a (GraphPad Software, United States). P 
Fgl2 Tg Treg have enhanced activity to prevent T cell induced colitis
We next studied the effect of fgl2
Tg Treg on the development of colitis [2] [3] [4] . For these studies, we isolated CD4
low Treg and CD4
Teff with a purity of > 98% using FACS (Figure 2 Figure 3A ). Mice that received fgl2 -/-or fgl2
Treg showed improved clinical activity within the first 4-6 wk, but these mice still demonstrated clinical signs of colitis including lethargy, piloerection and slight hunching. In contrast, all mice that received fgl2 Tg Treg appeared clinically normal and had weight gain similar to sham control mice ( Figure 3A ). Tissues were harvested and examined histologically from the ileum, the proximal, medial and distal colon at 14 wk post cell transfer. In all groups of mice, the ileum was near normal similar to what has been reported previously by other investigators [5] . As expected, the sham group showed normal colonic architecture with large numbers of goblet cells and normal crypt architecture ( Figure 3B ). In contrast, colons from mice that received Teff but no Treg cells showed large, diffuse areas of parenchymal disease characterized by villous flattening, large cellular infiltrates, destruction of crypts, severe mucin depletion and loss of goblet cells ( Figure 3B ). Colons from mice that received fgl2 -/-or fgl2 +/+ Treg had improved histology but still had patchy areas of colitis marked by T cell infiltrates, destruction of epithelial -/-or fgl2 +/+ Treg led to overall improved histology; however, numerous areas of patchy colonic disease were still seen. In contrast, colons from mice that received fgl2
Tg Treg were near normal. H&E; Original magnification 100 ×; C: Pathologic scoring of colon sections. Scoring was performed on H&E stained sections as described in the methods section. Data represent mean ± SEM. Pathology scores were obtained from 2 independent experiments with n ≥ 5 mice per group; D: Transfer of fgl2 Tg Treg does not alter FGL2 plasma levels during colitis. Blood from fgl2 +/+ , Rag1 -/-and, fgl2 Tg mice was collected prior to the induction of colitis (plasma levels in naïve mice). At sacrifice, blood was collected from each animal. Rag1 -/-mice received CD4 + CD25 -CD45RB hi T cells and Treg isolated from fgl2 +/+ or fgl2 Tg mice (Treg adoptively transferred into Rag1 -/-mice). Plasma levels of FGL2 were measured using an FGL2 ELISA. Statistical analysis was performed using a one-way ANOVA and Tukey's multiple comparison post-hoc test ( a P < 0.05, e P < 0.001). Treg: Regulatory T cells. Figure 3B ). Changes in histology were quantified using a modified pathology index established by Aranda et al [3] with a maximum pathology score of 12. Mice in the no Treg group had the highest score indicative of a pan diffuse colitis with disease across the proximal, mid and distal colon associated with diffuse parenchymal destruction, crypt loss, mucin depletion and dense lymphocyte infiltrates ( Figure 3C ). Mice that received fgl2 -/-or fgl2 +/+ Treg had similar overall pathology scores, which were significantly better than mice in the no Treg group. Colons from mice that received fgl2
Tg
Treg were near normal with normal numbers of crypt goblet cells; however, there were occasional patchy foci of inflammation and small numbers of crypt abscesses seen especially in the mid colon. These mice had a pathology score that was significantly better than mice that received either fgl2 -/-or fgl2 +/+ Treg ( Figure 3C ).
To determine if adoptive transfer of fgl2
Tg Treg could alter systemic levels of FGL2 we measured plasma levels of FGL2 in the Rag1 -/-mice. Interestingly, we found that there was no change in plasma levels of FGL2 following transfer of fgl2 Tg Treg ( Figure 3D ). These data suggest that the adoptively transferred fgl2 Tg Treg are working locally as opposed to systemically to limit colonic inflammation.
Fgl2 Tg Treg prevent infiltration of Teff into the colon of
Rag1 -/-mice
The colon and mesenteric lymph nodes (MLN) from all groups of mice were stained for the presence of CD3 Figure 4A ). These findings were confirmed by morphometry ( Figure 4C-E) . The ratio of Foxp3 + to CD3 + cells was highest in mice that received fgl2 Tg Treg (P < 0.001) ( Figure 4E ). Figure 4B-E) .
Effect of Treg on T Cell Proliferation assessed by Ki67 staining
To examine the influence of Treg on Teff cell proliferation, Ki67 staining was performed as described in the methods and by others [22] . 
DISCUSSION
IBD consists of a group of chronic relapsing inflammatory diseases of the gastrointestinal tract that include CD and ulcerative colitis [1] . The onset of colitis has been shown to be dependent on dysregulated innate and adaptive immune responses to bacterial flora [1] [2] [3] [4] [5] . Here we investigated the effect of overexpression of the Treg immunosuppressive effector molecule FGL2 in the T cell-induced mouse model of colitis. For these studies, we isolated Treg and Teff cells from transgenic mice that ubiquitously overexpress FGL2, which were recently generated in our laboratory [20] .
In vitro, fgl2
Tg Treg had enhanced suppressive activity compared with fgl2 +/+ Treg, and Treg are known to regulate the differentiation and proliferation of Teff by several mechanisms, including bystander suppression and/or by altering the cytokine milieu [11] . IL-10 has been shown to be important in the prevention of experimental IBD through binding with ) are as effective as Treg from normal mice in protecting against IBD suggesting that although IL-10 is important in protection against colitis, the source of IL-10 need not be from Treg [23] . FGL2 has previously been described as an important Treg immunosuppressive effector molecule [12] . Recently, FGL2 was shown to be critical for the immune suppressive activity of a major subset of Treg that express T cell immunoglobulin and ITIM domain (TIGIT) [10] . In those studies, TIGIT + Treg were shown to highly suppress TH1 and TH17 cell responses while preserving TH2 responses, which was dependent on FGL2 expression [10] . Both TIGIT -/-Treg and TIGIT
+
Treg inhibited T cell-induced colitis, but the role of FGL2 in colitis was not examined in their report [10] .
Others have reported that Treg can ameliorate Teff induced colitis in the Rag1
-/-mouse model [2] . Although mice infused with Treg had markedly reduced colitis, Treg treated mice still had evidence of disease as reflected by histology and pathologic scoring [2] . [10] . [20] . We also reported that tolerant heart allografts contain increased numbers of FGL2 + Treg whereas they were near absent in rejecting allografts [18] . Taken together, these data suggest Treg secreting high levels of FGL2 are critical to the establishment and maintenance of tolerance in both allo-transplantation and autoimmune disease. Clinical trials are currently underway to test the safety and efficacy of Treg populations in the treatment of IBD [24, 25] . [26, 27] . We also showed that recombinant FGL2 inhibits the maturation of bone marrowderived DC and promotes B cell apoptosis [26] . It is unlikely that FGL2 acts directly on Teff as T cells express little if any FcγRIIB [27] . Consistent with this, we have observed that recombinant FGL2 did not inhibit T cell proliferation when purified T cells were stimulated with anti-CD3 and anti-CD28 (data not shown). However, recombinant FGL2 inhibits T cell proliferation in mixed lymphocyte reactions when APC are present [28] . levels of FGL2 in patients with active IBD (CD and ulcerative colitis) [29] . In these patients, endothelial cells and infiltrating inflammatory cells in mucosal biopsy specimens stained strongly for FGL2. Together with our studies showing the immunosuppressive effects of FGL2, these data suggest that expression of FGL2 is an important regulator of mucosal immunity and may represent a feedback mechanism to limit inflammation in patients with active IBD [29] . Collectively, the studies presented here confirm that FGL2 is an important immunosuppressive effector.
Teff from fgl2
Tg mice are hypoproliferative and fail to induce colitis when injected into Rag1 -/-mice.
Treg from fgl2
Tg have increased immunosuppressive activity in vitro and protect mice from T cell-mediated colitis. These studies support the concept that FGL2 expressing Treg are critical for the maintenance of tolerance and provide a rationale for exploring the use of recombinant FGL2 or Treg expressing high levels of FGL2 in the treatment of autoimmune disease.
COMMENTS
Background
Inflammatory bowel disease (IBD) consists of a group of chronic relapsing inflammatory diseases of the gastrointestinal tract that include Crohn's disease and ulcerative colitis. Regulatory T cells (Treg) have been shown to be important regulators of disease activity in IBD and can ameliorate disease in the T cell-induced model of colitis in immunodeficient Rag1 -/-mice.
Research frontiers
Fibrinogen-like protein 2 (FGL2) is a newly described immunoregulatory molecule that is an effector molecule of Treg. The effect of overexpression of FGL2 in the T cell-induced model of colitis has not been studied previously.
We recently generated a transgenic line of mice that ubiquitously overexpress FGL2 (fgl2 Tg ). Here we isolated Treg and effector T cells (Teff) from fgl2 Tg mice and compared these cells to wildtype (fgl2 +/+ ) cells in the T cell-induced colitis model.
Innovations and breakthroughs
The authors found that fgl2
Tg Treg have enhanced immune suppressive activity compared with fgl2 +/+ Treg in vitro. Following injection in Rag1 -/-mice, fgl2 Tg Treg were present in high numbers in mesenteric lymph nodes and were superior to 
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